People: Urodynamix Technologies Ltd. (URO.V)

URO.V on TSX Venture Exchange

0.02CAD
8 Feb 2010
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.02
Open
--
Day's High
$0.02
Day's Low
$0.02
Volume
30,000
Avg. Vol
78,681
52-wk High
$0.17
52-wk Low
$0.02

view people for:

Summary

Name Age Since Current Position
Allen, Barry 2008 President, Chief Executive Officer, Director
Jackson, Jonathan 2008 Chief Financial Officer
Li, Luya 2005 Vice President - Technology
Gauthier, Greg 2008 Vice President - Business Development
Philp, Tanner 37 2007 Corporate Secretary
Geyer, Paul 45 2004 Director
Heppell, Jim 2005 Independent Director
Mohamedali, Zeid 2006 Director
Leduc, Pierre 2007 Director
Goodkin, David 50 2007 Director
» Insider Trading

Biographies

Name Description
Allen, Barry Barry J. Allen is President and CEO, Urodynamix Technologies Ltd. since June 14, 2005. Entrepreneur in Residence at Ventures West Management Inc. from March 2004 to April 2006. President and CEO of VSM MedTech Ltd. from March 1999 to February 2004. VP-Operations and Director of Clinical Research, Xillix Technologies Inc. from 1993 to 1999.
Jackson, Jonathan Mr. Jonathan G. E. Jackson, CA has been appointed as Chief Financial Officer of Urodynamix Technologies Ltd. Mr. Jackson has held CFO and VP Finance roles in high-tech and manufacturing companies for the past 12 years and was most recently the Chief Financial Officer at Extreme CCTV Inc., where he successfully completed the sale of that company to Robert Bosch GmbH of Germany. Mr. Jackson has a Bachelor of Commerce degree from the University of Saskatchewan and is a member of the Institute of Chartered Accountants of British Columbia.
Li, Luya Dr. Li is Vice President - Technology of Urodynamix Technologies Ltd. He has a PhD in Electrical Engineering and over 20 years experience in developing leading edge technologies. He was most recently a senior technical manager at VSM MedTech where he led the development of a medical device incorporating near-infrared optical sensing technology through its early stages, clinical studies and collaboration with development partners. Dr. Li has also held a variety of senior technical positions in research institutions and industrial high tech companies.
Gauthier, Greg Greg Gauthier has been appointed as Vice President of Business Development of Urodynamix Technologies Ltd. With over 20 years of experience in the pharmaceutical and medical device sectors, Mr. Gauthier has held progressive sales and business development positions with industry leaders across North America and Europe including Baxter Healthcare Corp., Siemens Healthcare, C. R. Bard Inc., AmerisourceBergen Corp. and Alaris Medical Systems (acquired by Cardinal Health Inc. in 2004). Mr. Gauthier has extensive experience taking new products into the healthcare market and aggressively executing innovative business development and joint venture strategies. He has been responsible for a number of successful marketing campaigns and new product introductions, successfully negotiating distribution agreements, managing distribution channels and establishing global dealer networks. Mr. Gauthier is a graduate of the University of Waterloo.
Philp, Tanner Mr. Philp is Corporate Secretary of Urodynamix Technologies Ltd. He currently serves as Chief Financial Officer and Partner of Lions Capital Corp., the fund manager of BC Advantage Funds (VCC) Ltd., a venture capital fund that invests in emerging technology and life science companies. Mr. Philp is a Director of Vigil Health Solutions Inc. and an advisor to a number of technology companies where he works to maximize value for investors. He specializes in working with early-stage public and private companies on business strategy development, funding, mergers and acquisitions and corporate partnering. Mr. Philp is a Chartered Accountant who began his career with KPMG Vancouver and subsequently worked for KPMG London (UK) where he specialized in providing consulting and corporate finance services. He holds a Bachelor of Business Administration in Finance from Simon Fraser University.
Geyer, Paul Paul Geyer Director of Urodynamix Technologies Ltd. He is Chairman, President and CEO, Medical Ventures Corp., since January 2002; President, Sulzer Mitroflow Corp. or predecessor companies from 1991 to 2001.
Heppell, Jim Mr. Jim Heppell is Director of Urodynamix Technologies Ltd. He is President and Fund Manager of BC Advantage Funds (VCC) Ltd. President and Chief Executive Officer of Catalyst Corporate Finance Lawyers to February 1, 2006; Director or Officer of several biotechnology companies.
Mohamedali, Zeid Dr. Mohamedali is Director of Urodynamix Technologies Ltd. He is Consulting Urologist at several hospitals in British Columbia; Fellow of the Royal College of Physicians & Surgeons (Urology).
Leduc, Pierre Pierre Leduc is Chairman of Urodynamix Technologies Ltd. He is Principal of Leduc Associates Management Consultants, a firm specializing in biotech companies, since July 2004; President and CEO of Neurostream Technologies Inc. from July 2001 to July 2004.
Goodkin, David Dr. Goodkin Director of Urodynamix Technologies Ltd. He is Principal of Goodkin Biopharma Consulting, LLC, since September 2007; Senior Vice President, Development and Chief Medical Officer of ICOS Corporation from August 2002 to January 2007; Vice President, Clinical Research, Amgen Inc. from February 1992 to July 2002.

Basic Compensation

Name Fiscal Year Total
Allen, Barry 339,800
Jackson, Jonathan 53,840
Li, Luya 178,900
Gauthier, Greg 119,667
Philp, Tanner --
Geyer, Paul --
Heppell, Jim --
Mohamedali, Zeid --
Leduc, Pierre --
Goodkin, David --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Allen, Barry 114,500 0
Jackson, Jonathan 0 0
Li, Luya 275,000 2,000
Gauthier, Greg 0 0
Philp, Tanner 0 0
Geyer, Paul 0 0
Heppell, Jim 0 0
Mohamedali, Zeid 0 0
Leduc, Pierre 0 0
Goodkin, David 0 0

Insider Trading

» Full list on Insider Trading
view people for: